TCRR   $1.48  -4.40% Market Closed

TCR2 Therapeutics Inc
Last Events:

2023-07-18 Trend pattern changed from канал to восходящий клин.

2023-07-18 Signal in Stochastic changed from bearish weakening to bearish recovery. The stochastic indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: entry into the oversold zone.

2023-07-18 Signal in MACD changed from bearish reversal to bearish. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: down-crossing the middle level.

2023-07-18 Signal in RSI changed from bullish recovery to bearish recovery. RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

2023-07-18 Signal in EMA100 changed from bullish reversal to bearish reversal. 2023-05-26 the price crossed down the moving average line and formed a short-term downside trend.

2023-07-18 Signal in EMA50 changed from bullish reversal to bearish reversal. 2023-05-26 the price crossed down the moving average line and formed a short-term downside trend.

2023-07-18 Signal in EMA20 changed from bullish reversal to bearish reversal. 2023-05-22 the price crossed down the moving average line and demonstrates a strong downside trend.

2023-05-20 Trend pattern changed from сужающийся канал to канал.


Current temperature: 2.82
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 1.36
Target: 6.43
High with 49% probability: 2.69
Analyst Recommendations:
Number of estimates 4
Target Price Mean 6.43
Mean unverified/preliminary 6.43 / 6.43
Target Price Low / High 1.72 / 20.00
Median / STD DEV 2.00 / 9.05
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi ActivelyBuy - Sell
macd - - -
stoch - - -
ma20 Sell Sell Sell
ma50 - - -
ma100 Sell Sell -
Candlestick PatternMay 30, 2023 Hammer - is a candlestick that consists of a small body near the high with a little or no upper shadow and a long lower tail. Considered to be a bullish pattern during a downtrend.
ISIN US87808K1060
ceo Dr. Garry E. Menzel M.B.A., Ph.D.
Website https://www.tcr2.com
TCR2 Therapeutics Inc., a clinical-stage cell therapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. Its lead product candidate is gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin-expressing solid tumors, which is in Phase 1/2 clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma. It is also developing TC-510, a mesothelin-targeted TRuC-T cell that has completed preclinical trials to treat solid tumors; and TC-520, a fratricide resistant CD70 targeting TRuC-T cell for the treatment of renal cell carcinoma and acute myeloid leukemia. The company was formerly known as TCR2, Inc. and changed its name to TCR2 Therapeutics Inc. in November 2016. TCR2 Therapeutics Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.